Journey Medical (DERM) Competitors $5.37 +0.17 (+3.27%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends DERM vs. AURA, ALMS, KALV, FHTX, TNGX, AQST, CGC, VERV, AKBA, and DNAShould you be buying Journey Medical stock or one of its competitors? The main competitors of Journey Medical include Aura Biosciences (AURA), Alumis (ALMS), KalVista Pharmaceuticals (KALV), Foghorn Therapeutics (FHTX), Tango Therapeutics (TNGX), Aquestive Therapeutics (AQST), Canopy Growth (CGC), Verve Therapeutics (VERV), Akebia Therapeutics (AKBA), and Ginkgo Bioworks (DNA). These companies are all part of the "pharmaceutical products" industry. Journey Medical vs. Aura Biosciences Alumis KalVista Pharmaceuticals Foghorn Therapeutics Tango Therapeutics Aquestive Therapeutics Canopy Growth Verve Therapeutics Akebia Therapeutics Ginkgo Bioworks Aura Biosciences (NASDAQ:AURA) and Journey Medical (NASDAQ:DERM) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, valuation, profitability, dividends, risk, media sentiment and institutional ownership. Is AURA or DERM more profitable? Aura Biosciences has a net margin of 0.00% compared to Journey Medical's net margin of -31.74%. Aura Biosciences' return on equity of -41.57% beat Journey Medical's return on equity.Company Net Margins Return on Equity Return on Assets Aura BiosciencesN/A -41.57% -36.43% Journey Medical -31.74%-132.10%-26.90% Does the media prefer AURA or DERM? In the previous week, Aura Biosciences had 4 more articles in the media than Journey Medical. MarketBeat recorded 13 mentions for Aura Biosciences and 9 mentions for Journey Medical. Aura Biosciences' average media sentiment score of 0.63 beat Journey Medical's score of 0.57 indicating that Aura Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aura Biosciences 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Journey Medical 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, AURA or DERM? Aura Biosciences has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500. Comparatively, Journey Medical has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Which has stronger earnings & valuation, AURA or DERM? Journey Medical has higher revenue and earnings than Aura Biosciences. Journey Medical is trading at a lower price-to-earnings ratio than Aura Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAura BiosciencesN/AN/A-$76.41M-$1.73-5.17Journey Medical$57.77M1.94-$3.85M-$0.94-5.71 Does the MarketBeat Community believe in AURA or DERM? Aura Biosciences received 18 more outperform votes than Journey Medical when rated by MarketBeat users. However, 100.00% of users gave Journey Medical an outperform vote while only 62.16% of users gave Aura Biosciences an outperform vote. CompanyUnderperformOutperformAura BiosciencesOutperform Votes2362.16% Underperform Votes1437.84% Journey MedicalOutperform Votes5100.00% Underperform VotesNo Votes Do insiders and institutionals have more ownership in AURA or DERM? 96.8% of Aura Biosciences shares are held by institutional investors. Comparatively, 7.3% of Journey Medical shares are held by institutional investors. 5.4% of Aura Biosciences shares are held by company insiders. Comparatively, 13.2% of Journey Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts recommend AURA or DERM? Aura Biosciences currently has a consensus price target of $23.00, indicating a potential upside of 156.98%. Journey Medical has a consensus price target of $9.38, indicating a potential upside of 74.58%. Given Aura Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe Aura Biosciences is more favorable than Journey Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aura Biosciences 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29Journey Medical 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 SummaryAura Biosciences beats Journey Medical on 11 of the 18 factors compared between the two stocks. Ad Darwin2025: Digital Asset Insights You Need to KnowCryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.Get your guide today! Get Journey Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DERM vs. The Competition Export to ExcelMetricJourney MedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$112.18M$6.63B$5.20B$8.83BDividend YieldN/A8.11%5.06%4.09%P/E Ratio-5.7110.49112.7217.51Price / Sales1.94368.691,242.97159.41Price / Cash29.5352.5939.8636.27Price / Book10.1310.367.056.49Net Income-$3.85M$152.98M$118.72M$225.45M7 Day Performance4.07%4.60%2.20%3.61%1 Month Performance-12.68%-7.69%-3.08%3.45%1 Year PerformanceN/A33.50%33.70%29.16% Journey Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DERMJourney Medical3.0562 of 5 stars$5.37+3.3%$9.38+74.6%N/A$112.18M$57.77M-5.7190Analyst RevisionAURAAura Biosciences3.5219 of 5 stars$8.95-0.9%$23.00+157.0%+12.2%$447.05MN/A-5.1950ALMSAlumisN/A$9.46+0.2%$26.83+183.7%N/A$446.70MN/A0.00N/AKALVKalVista Pharmaceuticals3.7632 of 5 stars$10.15+8.9%$26.00+156.2%+33.9%$438.63MN/A-2.88150Insider TradeFHTXFoghorn Therapeutics2.643 of 5 stars$7.84+1.6%$16.00+104.1%+79.8%$435.83M$34.15M-4.04120TNGXTango Therapeutics2.5022 of 5 stars$3.92+8.0%$13.14+235.3%-49.6%$421.09M$36.53M-3.3090AQSTAquestive Therapeutics2.2799 of 5 stars$4.56+1.1%$9.80+114.9%+123.5%$415.77M$58.90M-10.20160Positive NewsCGCCanopy Growth1.3427 of 5 stars$3.90+1.0%$3.50-10.3%-32.4%$410.90M$220.27M-0.781,029VERVVerve Therapeutics2.2323 of 5 stars$4.85+5.4%$25.75+430.9%-59.7%$410.60M$11.76M0.00110Gap DownAKBAAkebia Therapeutics3.942 of 5 stars$1.88+3.3%$5.75+205.9%+89.9%$410.18M$169.88M-7.91167Analyst DowngradeDNAGinkgo Bioworks1.2821 of 5 stars$7.18+9.0%$4.58-36.3%N/A$399.06M$251.46M-0.541,218Positive News Related Companies and Tools Related Companies Aura Biosciences Competitors Alumis Competitors KalVista Pharmaceuticals Competitors Foghorn Therapeutics Competitors Tango Therapeutics Competitors Aquestive Therapeutics Competitors Canopy Growth Competitors Verve Therapeutics Competitors Akebia Therapeutics Competitors Ginkgo Bioworks Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DERM) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
